Efficacy and safety of risvutatug rezetecan versus gemcitabine–docetaxel in relapsed or refractory osteosarcoma: primary results from the ARTEMIS-011 phase III trial ☆
Publication date: Available online 26 October 2026 Source: Annals of Oncology Author(s): L. Xie, W. Yao, Y. Hua, W. Luo, C. Tu, J. Wang, J. Chen, B. Li, D. Zhu, X. Li, Y. Xiao, J. Ma, H. Hu, M. Fang, Z. Huang, H. Wang, Q. Liu, Y. Jin, X. Zhang, X. Niu
Efficacy and safety of risvutatug rezetecan versus gemcitabine–docetaxel in relapsed or refractory osteosarcoma: primary results from the ARTEMIS-011 phase III trial ☆. // Annals of Vascular Surgery. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426080762?dgcid=rss_sd_all
Efficacy and safety of risvutatug rezetecan versus gemcitabine–docetaxel in relapsed or refractory osteosarcoma: primary results from the ARTEMIS-011 phase III trial ☆. Annals of Vascular Surgery. https://www.sciencedirect.com/science/article/pii/S0923753426080762?dgcid=rss_sd_all
“Efficacy and safety of risvutatug rezetecan versus gemcitabine–docetaxel in relapsed or refractory osteosarcoma: primary results from the ARTEMIS-011 phase III trial ☆.” Annals of Vascular Surgery.
@article{article3531,
title = {Efficacy and safety of risvutatug rezetecan versus gemcitabine–docetaxel in relapsed or refractory osteosarcoma: primary results from the ARTEMIS-011 phase III trial ☆},
journal = {Annals of Vascular Surgery},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426080762?dgcid=rss_sd_all}
}
Increasing One Health awareness at the local level and funding risk-communication for farmers and animal health communities could have a positive impact on surveillance systems through normalizing surveillance effort. This is one of the...
In recent decades, Ophidiomyces ophidiicola (Oo), the fungal pathogen known to cause ophidiomycosis, has been detected in snake populations across multiple continents. Ophidiomycosis, commonly known as snake fungal disease, has been...
This study investigates whether climate suitability predicts malaria and leishmaniasis burden in the WHO Eastern Mediterranean countries (2000–2023). Multi-linear regressions models. Climate suitability models were developed using ERA5...
Q fever is often underrecognized when direct exposure is not reported. We describe three acute cases in northeastern Italy, including a severe case with an additional E. chaffeensis/E. muris-group molecular signal detected by multiplex...
Human exposure to zoonotic diseases is rising, with serious implications for global health. Although research into zoonotic diseases has advanced in identifying the ecological drivers of pathogen spillover, comprehensive comparisons of...